Nektar Therapeutics banner

Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 72.08 USD -1.21%
Market Cap: $2B

Balance Sheet

Balance Sheet Decomposition
Nektar Therapeutics

Balance Sheet
Nektar Therapeutics

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
35
44
32
261
64
76
156
50
18
15
25
39
12
56
60
5
195
96
199
25
88
35
44
15
Cash Equivalents
35
44
32
261
64
76
156
50
18
15
25
39
12
56
60
5
195
96
199
25
88
35
44
15
Short-Term Investments
259
242
212
215
395
406
223
347
298
226
252
198
226
253
330
291
1 140
1 229
863
709
417
268
211
231
Total Receivables
4
6
13
13
47
22
11
5
25
5
6
2
4
20
16
5
43
37
39
23
6
1
0
2
Accounts Receivables
4
6
13
13
47
22
11
5
25
5
6
2
4
20
16
5
43
37
39
23
6
1
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
6
9
11
19
15
12
9
7
7
13
18
14
13
11
11
11
11
13
15
16
19
16
0
0
Other Current Assets
6
6
12
13
15
7
7
6
6
18
13
5
34
10
10
15
48
47
22
23
16
10
6
39
Total Current Assets
311
307
280
520
535
523
406
414
354
277
315
258
288
350
426
327
1 438
1 422
1 138
796
546
331
261
266
PP&E Net
144
149
151
142
134
114
74
78
90
79
72
67
70
71
66
48
49
199
186
178
86
37
12
5
PP&E Gross
144
149
151
142
134
114
74
78
90
79
72
67
70
71
66
48
49
199
186
178
86
37
12
0
Accumulated Depreciation
50
59
64
87
107
106
44
54
54
62
73
84
94
103
111
115
121
128
139
148
125
87
16
0
Intangible Assets
16
11
7
14
4
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
130
130
130
78
78
78
77
77
77
77
77
77
77
77
77
77
77
77
77
77
77
0
0
0
Long-Term Investments
0
12
175
90
8
0
0
0
0
174
0
0
0
0
0
57
583
279
137
65
0
26
26
3
Other Long-Term Assets
7
7
3
15
9
6
4
7
1
1
34
33
7
1
1
1
4
1
2
3
2
5
5
6
Other Assets
130
130
130
78
78
78
77
77
77
77
77
77
77
77
77
77
77
77
77
77
77
0
0
0
Total Assets
607
N/A
617
+2%
745
+21%
859
+15%
768
-11%
725
-6%
561
-23%
576
+3%
521
-9%
607
+16%
498
-18%
435
-13%
442
+2%
499
+13%
569
+14%
509
-11%
2 150
+323%
1 977
-8%
1 539
-22%
1 117
-27%
711
-36%
398
-44%
304
-24%
280
-8%
Liabilities
Accounts Payable
9
8
7
16
7
4
14
3
7
3
3
9
3
2
3
5
6
19
22
10
13
10
12
11
Accrued Liabilities
32
19
17
27
35
70
39
29
30
31
41
44
27
23
35
32
62
80
94
76
55
41
50
43
Short-Term Debt
0
0
0
0
103
0
0
0
0
215
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
2
1
1
2
0
0
0
0
0
0
5
5
0
0
0
249
0
0
0
0
0
0
Other Current Liabilities
22
19
30
26
20
22
15
121
27
26
34
45
30
32
34
19
14
6
0
0
0
0
0
0
Total Current Liabilities
64
47
56
70
166
98
68
153
64
276
79
98
64
61
72
56
82
354
116
85
68
51
61
54
Long-Term Debt
331
392
198
438
335
337
235
234
232
15
137
203
129
243
244
245
247
0
0
0
0
113
92
63
Other Liabilities
5
14
24
24
41
76
67
86
135
119
236
223
212
188
165
120
104
218
346
353
276
103
90
74
Total Liabilities
400
N/A
453
+13%
278
-39%
532
+92%
541
+2%
511
-6%
370
-27%
473
+28%
431
-9%
409
-5%
451
+10%
524
+16%
405
-23%
492
+21%
481
-2%
421
-12%
433
+3%
572
+32%
462
-19%
438
-5%
344
-21%
267
-22%
243
-9%
191
-22%
Equity
Common Stock
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
549
615
717
902
1 057
1 090
1 124
1 227
1 265
1 399
1 570
1 732
1 786
1 868
2 021
2 118
1 424
1 865
2 309
2 833
3 201
3 477
3 596
3 760
Additional Paid In Capital
715
779
1 188
1 234
1 284
1 303
1 313
1 328
1 354
1 597
1 618
1 644
1 824
1 876
2 112
2 208
3 148
3 271
3 389
3 517
3 575
3 608
3 660
3 850
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
Other Equity
1
1
3
5
0
2
1
1
1
1
0
1
2
2
2
2
6
1
2
4
7
0
0
0
Total Equity
207
N/A
164
-21%
467
+185%
327
-30%
227
-31%
214
-6%
190
-11%
102
-46%
91
-11%
198
+118%
47
-76%
90
N/A
36
N/A
6
-82%
88
+1 277%
88
0%
1 718
+1 856%
1 405
-18%
1 077
-23%
680
-37%
367
-46%
131
-64%
61
-54%
90
+48%
Total Liabilities & Equity
607
N/A
617
+2%
745
+21%
859
+15%
768
-11%
725
-6%
561
-23%
576
+3%
521
-9%
607
+16%
498
-18%
435
-13%
442
+2%
499
+13%
569
+14%
509
-11%
2 150
+323%
1 977
-8%
1 539
-22%
1 117
-27%
711
-36%
398
-44%
304
-24%
280
-8%
Shares Outstanding
Common Shares Outstanding
4
4
6
6
6
6
6
6
6
8
8
8
9
9
11
11
12
12
12
12
13
13
12
20
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett